<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00481312</url>
  </required_header>
  <id_info>
    <org_study_id>3005013</org_study_id>
    <nct_id>NCT00481312</nct_id>
  </id_info>
  <brief_title>Dexmedetomidine Versus Midazolam for Continuous Sedation in the Intensive Care Unit (ICU)</brief_title>
  <acronym>MIDEX</acronym>
  <official_title>A Prospective, Multi-centre, Randomised, Double-blind Comparison of Intravenous Dexmedetomidine With Midazolam for Continuous Sedation of Ventilated Patients in Intensive Care Unit</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Orion Corporation, Orion Pharma</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Orion Corporation, Orion Pharma</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients in ICU who need help with their breathing are put onto a machine called a ventilator&#xD;
      and are also given a medicine, called a sedative, which helps them to sleep and makes them&#xD;
      more comfortable. Midazolam is a sedative that is routinely used for these purposes.&#xD;
&#xD;
      For most patients the aim of sedation is to make them sleepy but still able to respond to&#xD;
      nursing staff (light sedation)&#xD;
&#xD;
      Dexmedetomidine is a new sedative for use in intensive care and in this clinical study,&#xD;
      dexmedetomidine is compared to midazolam. It is thought that dexmedetomidine might be&#xD;
      slightly better at allowing patients to be sleepy but still respond to people around them. It&#xD;
      also does not appear to affect patient's breathing. the purpose of this study is to test&#xD;
      whether dexmedetomidine really does have these advantages compared to midazolam.&#xD;
&#xD;
      in this study we hope to show that: dexmedetomidine is at least as good as midazolam in&#xD;
      helping patients to sleep better and making them more comfortable, and that they are able to&#xD;
      co-operate better with the staff treating them, and that patients treated with&#xD;
      dexmedetomidine require a shorter time on the ventilator than those treated with midazolam.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a phase III, multi-centre, prospective, randomised, double-blind, double-dummy,&#xD;
      active comparator study. The study consists of three periods: screening, double-dummy&#xD;
      treatment and follow-up period.&#xD;
&#xD;
      All patients admitted to ICU will be pre-screened according to inclusion and exclusion&#xD;
      criteria prior to informed consent using available clinical data.&#xD;
&#xD;
      Informed consent, screening and randomisation procedures should be completed within 72 hours&#xD;
      from the time of admission to ICU and within 48 hours from starting continuous sedation.&#xD;
      Eligible study subjects requiring light to moderate sedation (Richmond Agitation-Sedation&#xD;
      Scale [RASS] = 0 to -3) will be randomised to either continue on midazolam or switch to&#xD;
      dexmedetomidine. Patients should not have received any other continuously or regularly&#xD;
      administered sedative agent than midazolam infusion during the last 12 hours except for&#xD;
      opioid analgesics. Study treatments will be titrated to achieve an individually targeted&#xD;
      sedation range determined on a daily basis. Rescue treatment (i.e. propofol boli) may be&#xD;
      given if needed to achieve the target depth of sedation. Continued need for sedation will be&#xD;
      assessed at a daily sedation stop, conducted at the same time each day. First sedation stop&#xD;
      may be 12-36 hours from randomisation, depending on the time of day the study subject is&#xD;
      randomised. The duration of study treatment is limited to a maximum of 14 days from&#xD;
      randomisation. Following withdrawal of sedation, study subjects will be monitored for 48&#xD;
      hours and contacted by telephone 31 and 45 days after randomisation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2007</start_date>
  <completion_date type="Actual">October 2009</completion_date>
  <primary_completion_date type="Actual">August 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Depth of sedation using the RASS. The target RASS range (target depth of sedation) should be 0 to -3 for a patient to be included in the study. The target may be amended during the study treatment, if clinically required</measure>
    <time_frame>RASS score will be assessed approximately 2 hourly during the treatment period and during the 48-hour follow-up period</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Duration of mechanical ventilation the number of days the patient receives mechanical ventilation will be recorded</measure>
    <time_frame>This variable will be dependent on the individual patient and the number of days they require mechanical ventilation .</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Nurse's assessment of subject communication with visual analogue scales (VAS)Patients rousability and ability to co-operate and communicate will be measured using a visual analogue scale.</measure>
    <time_frame>This will be measured at the end of every nursing shift whilst the patient remains on study treatment (maximum 14 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of ICU stay</measure>
    <time_frame>Number of days a patient is in ICU which will vary depending on the underlying illness of the patient</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">501</enrollment>
  <condition>Continuous Sedation in Initially Sedated Adults in ICU</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dexmedetomidine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Midazolam</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>Continuous Infusion</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam</intervention_name>
    <description>Continuous Infusion</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18 years and over&#xD;
&#xD;
          -  Clinical need for sedation of an initially intubated (or tracheotomised) and&#xD;
             ventilated (with inspiratory assistance) patient&#xD;
&#xD;
          -  Prescribed light to moderate sedation (target RASS = 0 to -3) using midazolam infusion&#xD;
&#xD;
          -  Patients should be randomised within 72 hours from ICU admission and within 48 hours&#xD;
             of commencing continuous sedation in the ICU&#xD;
&#xD;
          -  Patients should have an expected requirement for sedation of at least 24 hours from&#xD;
             time of randomisation&#xD;
&#xD;
          -  Written informed consent must be obtained according to local regulations before&#xD;
             starting any study procedures other than pre-screening.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Acute severe intracranial or spinal neurological disorder due to vascular causes,&#xD;
             infection, intracranial expansion or injury&#xD;
&#xD;
          -  Uncompensated acute circulatory failure at time of randomisation (severe hypotension&#xD;
             with MAP &lt; 55 mmHg despite volume and pressors)&#xD;
&#xD;
          -  Severe bradycardia (HR &lt; 50 beats/min)&#xD;
&#xD;
          -  AV-conduction block II-III (unless pacemaker installed)&#xD;
&#xD;
          -  Severe hepatic impairment (bilirubin &gt; 101 µmol/L)&#xD;
&#xD;
          -  Need for muscle relaxation at the time of randomisation (may only be used for&#xD;
             intubation and initial stabilization)&#xD;
&#xD;
          -  Loss of hearing or vision, or any other condition which would significantly interfere&#xD;
             with the collection of study data&#xD;
&#xD;
          -  Burn injuries requiring regular anaesthesia or surgery&#xD;
&#xD;
          -  Use of centrally acting α2 agonists or antagonists at the time of randomisation,&#xD;
             notably clonidine (see section 5.7 for prior and concomitant treatments)&#xD;
&#xD;
          -  Known allergy to any of the study drugs or any excipients of the study drugs&#xD;
&#xD;
          -  Patients who have or are expected to have treatment withdrawn or withheld due to poor&#xD;
             prognosis&#xD;
&#xD;
          -  Patients receiving sedation for therapeutic indications rather than to tolerate the&#xD;
             ventilator (e.g. epilepsy)&#xD;
&#xD;
          -  Patients unlikely to require continuous sedation during mechanical ventilation (e.g.&#xD;
             Guillain-Barré syndrome)&#xD;
&#xD;
          -  Patients who are unlikely to be weaned from mechanical ventilation; e.g.&#xD;
             diseases/injuries primarily affecting the neuromuscular function of the respiratory&#xD;
             apparatus such as clearly irreversible disease requiring prolonged ventilatory support&#xD;
             (e.g. high spinal cord injury or advanced amyotrophic lateral sclerosis)&#xD;
&#xD;
          -  Distal paraplegia&#xD;
&#xD;
          -  Positive pregnancy test or currently lactating&#xD;
&#xD;
          -  Received any investigational drug within the preceding 30 days&#xD;
&#xD;
          -  Concurrent participation in any other interventional study (any study in which&#xD;
             patients are allocated to different treatment groups and/or non-routine diagnostic or&#xD;
             monitoring procedures are performed)&#xD;
&#xD;
          -  Previous participation in this study&#xD;
&#xD;
          -  Any other condition which, in the investigator's opinion, would make it detrimental&#xD;
             for the subject to participate in the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephan Jakob, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Insel Spital, Bern CH-3010 Switzerland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Angela Ruck, BSc PhD</last_name>
    <role>Study Director</role>
    <affiliation>Orion Pharma R&amp;D Nottingham England</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>ULB Erasme, Route de Lennik</name>
      <address>
        <city>Brussels</city>
        <zip>1070</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UZ Brussel, Intensive Care Dept. Laarbeeklaan 101</name>
      <address>
        <city>Brussels</city>
        <zip>1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaer Ziekenhuis Gent, Intensieve Zorgen, De Pintelaan 185</name>
      <address>
        <city>Gent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Liege (Sart Tilman), Domaine de Sart-Tilman</name>
      <address>
        <city>Liege</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>East Tallinn Central Hospital, Ravi Stret 18</name>
      <address>
        <city>Tallinn</city>
        <zip>10138</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Estonian Regional Hospital, Centre of Intensive Care, J. Sutiste Tee 18</name>
      <address>
        <city>Tallinn</city>
        <zip>13419</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Estonian Regional Hospital, Dept. of Postoperative Intensive Care, J. Sutiste Tee 18</name>
      <address>
        <city>Tallinn</city>
        <zip>13419</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tartu University Hospistal, Clinic of Anesthesiology and Intensive Care, L. Puusepa 8</name>
      <address>
        <city>Tartu</city>
        <zip>51014</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oulu University Hospital, Kajaanintie 50</name>
      <address>
        <city>Oulu</city>
        <zip>90029 OYS</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tampere University Hospital, ICU</name>
      <address>
        <city>Tampere</city>
        <zip>33521</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire d'Angers, Reanimation medicale est de Mededicne Hyperbare, 4 Rue Larrey</name>
      <address>
        <city>Angers cedex 9</city>
        <zip>49933</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Victor Dupouy Hopital Dupuytren, Service Reanimation Polyvalente, 69, Rue du Lt Colonel Prud'hon</name>
      <address>
        <city>Argenteuil</city>
        <zip>95107</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Grenoble, Service de Reanimation Medicale, Boulevard de la Chantourne, BP 217</name>
      <address>
        <city>Grenoble cedex 09</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier La Roche sur Yon CHD les Oudaireis, Service Reanimation CHD la Roche sur Yon, Les Oudairies</name>
      <address>
        <city>La Roche sur Yon Cedex</city>
        <zip>85925</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Albert Calmette, Boulevard Du Pr. Jules Leclercq</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Limoges Hopital Dupuytren, Service de Reanimation Polyvalente, 2, Avenue Martin Luther King</name>
      <address>
        <city>Limoges</city>
        <zip>87042</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire d'Orleans, Reanimation Medicale, 1, rue Prote Madeleine, BP 2439</name>
      <address>
        <city>Orleans cedex 1</city>
        <zip>45032</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Bichat-Claude, Dept. D'Anasehesie et Reanimation Chirurgicale, 46, rue Henri-Huchard</name>
      <address>
        <city>Paris</city>
        <zip>75018</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier Cochin Saint Vincent de Paul, Service de Reanimation Medicale, 27 Rue du Faubourg Saint Jacques</name>
      <address>
        <city>Paris</city>
        <zip>75679</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Foch, Service Renimation, 40 Rue Worth, Suresnes Hauts de Seine</name>
      <address>
        <city>Paris</city>
        <zip>92150</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Poitiers, Reanimation Medicale, 2, Rue de la Miletrie</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Regional et Universitaire - Hopital Bretonneau Service Reanimation Medicale Polyvalente, 2, Boulevard Tonnelle, Tours cedex 9</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitatsklinikum Bonn, Klinik u. Poliklinik f. Anasthesiologie u. Operative Intensivmedizin, Sigmund-Freud-Strasse 25</name>
      <address>
        <city>Bonn</city>
        <zip>53105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitatsklinikum Greifswald, Klinik u. Poliklinik f. Anasthesiologie u. Intensivmedizin, Friedrich-Loeffler-Str. 23b</name>
      <address>
        <city>Greifswald</city>
        <zip>17475</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitatsklinikum Tubingen, Klinik fur Anasthesiologie und Intensivmedizin, Hoppe-Seyler-Strasse 3</name>
      <address>
        <city>Tubingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VU Medisch Centrum, De Boelelaan 1117</name>
      <address>
        <city>Amsterdam</city>
        <zip>1081 HV</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gelre Hospitals - Locatie Lucas, A.Schweitzerlaan 32</name>
      <address>
        <city>Apeldoorn</city>
        <zip>7334 DZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Amphia Ziekenhuis, Dept. Intensieve Zorgen, Molengracht 21</name>
      <address>
        <city>Breda</city>
        <zip>4818</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Albert Schweitzer Hospital, Locatie Dordwikj, Albert Schweitzerplaats 25</name>
      <address>
        <city>Dordrecht</city>
        <zip>3318 AT</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kennemer Hospital, Boeerhaavelaan 29</name>
      <address>
        <city>Haarlem</city>
        <zip>2035 RC</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Elisabeth Ziekenhuis, Dept. Intensieve Zorgen, Hilvarenbeekseweg 60</name>
      <address>
        <city>Tilburg</city>
        <zip>5022 GC</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Viecuri MC voor Noord-Limburg, Locatie Venlo, Dept. Intensieve Zorgen, Tegelseweg 210</name>
      <address>
        <city>Venlo</city>
        <zip>5912 BL</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Isala Klinieken, Locatie Weezenlanden, Groot Wezenland 20</name>
      <address>
        <city>Zwolle</city>
        <zip>8011 JW</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Haukeland University Hospital, Intensive Care Unit, Jonas Liesvei 65</name>
      <address>
        <city>Bergen</city>
        <zip>5021</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rikshospitalet, Universitetsklinikk, Sognsvannsveien 20</name>
      <address>
        <city>Oslo</city>
        <zip>0027</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ulleval University Hospital, Medical and Surgical ICU, Kirkeveien 166</name>
      <address>
        <city>Oslo</city>
        <zip>0450</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aker Universtetssykehus HF, Anestesiavdelingen, Trondheimsveien 235</name>
      <address>
        <city>Oslo</city>
        <zip>0514</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inselspital, Freiburgstrasse 4</name>
      <address>
        <city>Bern</city>
        <zip>CH-3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kantonsspital Winterthur, Brauerstrasse 15,</name>
      <address>
        <city>Winterthur</city>
        <zip>8401</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitatsspital Zurich, Klinik fur Innere Medizin, Intensivstation, Ramistrasse 100</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Birmingham, Department of Anaesthesia, Queen Elizabeth Hospital,</name>
      <address>
        <city>Birmingham</city>
        <zip>B15 2TH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Birmingham Heartlands Hospital, Bordesely Green East</name>
      <address>
        <city>Birmingham</city>
        <zip>B9 5SS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Derriford Hospital, Dept. of Intensive Care Level 4, Derriford Road</name>
      <address>
        <city>Plymouth</city>
        <zip>PL6 8DH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Estonia</country>
    <country>Finland</country>
    <country>France</country>
    <country>Germany</country>
    <country>Netherlands</country>
    <country>Norway</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>November 2009</verification_date>
  <study_first_submitted>May 31, 2007</study_first_submitted>
  <study_first_submitted_qc>May 31, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 1, 2007</study_first_posted>
  <last_update_submitted>May 4, 2012</last_update_submitted>
  <last_update_submitted_qc>May 4, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 7, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Initial Sedation</keyword>
  <keyword>Mechanical ventilation</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

